Savient Pharmaceuticals (SVNT) announces the formation of an Office of the President, consisting...

|About: Savient Pharmaceuticals, Inc. (SVNTQ)|By:, SA News Editor

Savient Pharmaceuticals (SVNT) announces the formation of an Office of the President, consisting of Richard Crowley, who will serve as Co-President and COO, John P. Hamill, who will serve as Co-President and CFO, and Philip K. Yachmetz, who will serve as Co-President and Chief Business Officer. Savient also says that Louis Ferrari, President, CEO, and Director, is leaving the Company to pursue other interests, effective immediately. Shares -4.3% AH.